by Nancy Reau (Author),‎ Donald M. Jensen (Author)

Fueled in part by the opioid epidemic, the number of reported hepatitis C virus infections tripled in the United States between 2010 and 2015. As new infections continue to mount, new therapies have produced seismic changes in how HCV is treated clinically, leaving a gap between the most current clinical guidance and the ongoing demands of patient care.

The New Hepatitis C is a current and essential review of HCV’s epidemiology, diagnosis, and clinical approaches — a clinician’s guidebook for navigating everything from screening to treatment. Acute and chronic HCV are addressed, as are important new treatment options for HCV, management of side effects, and a convenient summary of clinical trials on the treatment of chronic hepatitis C.

Updated to detail the standards of care that will define the next decade of HCV management, this evidence-based volume is an essential clinical reference for any practitioner in gastroenterology, hepatology, infectious disease, transplant, or internal medicine.

Product Details

• Series: Oxford American Infectious Disease Library
• eBook Digital: 200 pages
• Publisher: Oxford University Press; 2 edition (March 23, 2018)
• Language: English
• ISBN-10: 0190238283
• ISBN-13: 978-0190238285
• Product Dimensions: 7.8 x 0.7 x 5 inches

Living in a world where diseases rapidly spread and new epidemics are becoming more frequent, it is crucial for healthcare professionals to stay up-to-date with the latest information and clinical approaches. One such epidemic is hepatitis C, which has seen a triple increase in reported cases in the United States between 2010 and 2015. In light of these alarming statistics, Nancy Reau and Donald M. Jensen have collaborated to create a comprehensive and indispensable guidebook for clinicians: The New Hepatitis C.

The authors begin by addressing the alarming rise in hepatitis C infections, fueled in part by the opioid epidemic. This sets the stage for understanding the urgent need for up-to-date information on the diagnosis and treatment of HCV. With new therapies producing seismic changes in clinical practices, there is a gap between the latest clinical guidance and the demands of patient care. Reau and Jensen fill this void by providing clinicians with a meticulously researched and easily navigable resource.

The book covers a wide range of topics related to HCV, including its epidemiology, diagnosis, and clinical approaches. Both acute and chronic HCV are thoroughly discussed, ensuring that clinicians are equipped to address patients in various stages of the disease. In addition, important new treatment options for HCV are outlined, along with the management of side effects. To further assist clinicians, the book also includes a convenient summary of clinical trials on the treatment of chronic hepatitis C.

One of the standout features of The New Hepatitis C is its commitment to being an evidence-based reference. The authors provide the most up-to-date information on the standards of care that will shape the next decade of HCV management. This ensures that clinicians have access to the most current and effective treatments for their patients.

Given the ever-changing landscape of medical literature and the rapid pace of clinical advancements, it is essential for healthcare professionals to have a reliable and trustworthy resource at hand. Reau and Jensen have expertly filled this need with their comprehensive and practical guidebook. Whether you are a practitioner in gastroenterology, hepatology, infectious disease, transplant, or internal medicine, The New Hepatitis C will be an invaluable asset in your clinical practice.

Experience the peace of mind and confidence that comes with being armed with the latest knowledge and clinical approaches. Order your copy of The New Hepatitis C today and be at the forefront of HCV management.